Clinical Neuropsychologist Online
  • Clinical Neuropsychologist
    • Neuropsychological Assessment
      • What is Clinical Neuropsychology?
      • Our Clinical Neuropsychology Consults
        • Post-COVID Neuropsychological Assessment
    • Our Clinical Neuropsychologist
      • Clinical Neuropsychologist Referral
      • Clinical Neuropsychology Intake Upload
    • Clinical Neuropsychologist Online Appointments
      • Intake Appointment
      • Neuropsychologist Consult
      • Neuropsychology Feedback Session
  • Neuropsychology Knowledgebase
    • Acquired Brain Injury
    • Alzheimer’s Disease Neuropsychology
    • COVID-19 Neuropsychology
    • Dementia Neuropsychology
    • Memory Neuropsychology
    • Neuroanatomy & Neuroradiology
    • Neuropsychological Assessment
    • Neuropsychological Disorders
    • Psychometrics in Neuropsychology
  • Neuropsychology CPD
    • Latest Journal Articles
    • Cognitive Neuropsychology
    • Dementia
    • Neuro Podcasts
    • Neuroimaging
    • Neuropsychology (general)
    • Neurorehabilitation
    • Neuroscience
    • Paediatric Neuropsychology
  • Neuropsychology Courses
  • Newsletter
  • Brain Lounge
Select Page

Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer’s disease in the EMIF‐AD study

by Clinical Neuropsychologist | Wednesday, August 28, 2024 | Dementia

Abstract INTRODUCTION We investigated blood DNA methylation patterns associated with 15 well-established cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease (AD) pathophysiology, neuroinflammation, and neurodegeneration. METHODS We assessed DNA...

Blood‐based multivariate methylation risk score for cognitive impairment and dementia

by Clinical Neuropsychologist | Wednesday, August 28, 2024 | Dementia

Abstract INTRODUCTION The established link between DNA methylation and pathophysiology of dementia, along with its potential role as a molecular mediator of lifestyle and environmental influences, positions blood-derived DNA methylation as a promising tool for early...

How fiber bundle alterations differ in presumed LATE and amnestic Alzheimer’s disease

by Clinical Neuropsychologist | Wednesday, August 28, 2024 | Dementia

Abstract INTRODUCTION Typical Alzheimer’s disease (AD) and limbic-predominant age-related TAR DNA-binding protein 43 (TDP-43) encephalopathy (LATE) are two neurodegenerative diseases that present with a similar initial amnestic clinical phenotype but are...

The moderating role of information processing speed in the relationship between brain remodeling and episodic memory in amnestic mild cognitive impairment

by Clinical Neuropsychologist | Wednesday, August 28, 2024 | Dementia

Abstract INTRODUCTION The role of information processing speed (IPS) on relationships between episodic memory (EM) and central remodeling features in amnestic mild cognitive impairment (aMCI) was investigated. METHODS Neuropsychological evaluations and multimodal...

Alzheimer’s disease and its family history reduce the risk of non‐Hodgkin’s lymphoma: A Mendelian randomization study

by Clinical Neuropsychologist | Wednesday, August 28, 2024 | Dementia

Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Zilong Wang, Binyang Song, Jinhua Wang, Xiaobo Wang, Bo Tang |...
« Older Entries
Next Entries »

Posts by Category

  • Cognitive Neuropsychology
  • Dementia
  • Neuro Podcasts
  • Neuroimaging
  • Neuropsychology (general)
  • Neurorehabilitation
  • Neuroscience
  • Paediatric Neuropsychology

Neuropsychology Newsletter &
Interest List

S U B S C R I B E

  • X
  • RSS
© PsyAsia Neuropsychology. Clinical Neuropsychologist Hong Kong & Online. Part of the Psychology1 Group. All Rights Reserved.
DISCLAIMER: We are not responsible for any inaccuracies at this site. No medical advice is being offered to you personally.
No medical contract is formed by you visiting PsyAsia Neuropsychology.